A CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY

• 收藏
• 分享

专利权人:

IMMODULON THERAPEUTICS LIMITED

发明人:

AKLE, CHARLES,GRANGE, JOHN,BILYARD, KEVIN

申请号：

SG11201604602T

公开号：

SG11201604602TA

申请日:

2014.12.16

申请国别(地区):

SG

年份:

2016

代理人:

摘要：

An immunomodulator is for use in the treatment, reduction, inhibition or control of a neoplastic disease in a patient intended to undergo checkpoint inhibition therapy, simultaneously, separately or sequentially with administration of the immunomodulator. The immunomodulator preferably includes a whole cell Mycobacterium, such as M. vaccae or M. obuense.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/